Ce Li

Ministry of Education of the People's Republic of China — China

Medicine · Health Sciences

27h-index2.2kcitations106works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(28), Cancer-related molecular mechanisms research(15), RNA modifications and cancer(14), MicroRNA in disease regulation(12), Ferroptosis and cancer prognosis(11)

Publications106 total

Comparative Analysis of the Composition of Exosome-like Nanoparticles from Dried and Fresh Portulaca oleracea L.
Molecules·2025Open Access
MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway
Journal of Experimental & Clinical Cancer Research·2025· 3 citedOpen Access
T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers
Nature Communications·2025· 7 citedOpen Access
ANXA10 sensitizes microsatellite instability-high colorectal cancer to anti-PD-1 immunotherapy via assembly of HLA-DR dimers by regulating CD74
Cell Biology and Toxicology·2025· 1 citedOpen Access
Enriched Environment Ameliorates Cerebral Ischemia-Reperfusion Injury Via Dopamine-H₂S Axis-Mediated Dual Mitophagy Activation
SSRN Electronic Journal·2025Open Access
Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction
The International Journal of Cardiovascular Imaging·2024· 4 cited
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis
BMC Cancer·2023· 8 citedOpen Access
Identification and validation of basic fibroblast growth factor as a prognostic biomarker for the response of lung adenocarcinoma patients to bevacizumab treatment
Immunobiology·2023· 1 cited
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis
Research Square (Research Square)·2023Open Access
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
BMC Cancer·2023· 21 citedOpen Access
Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis
Frontiers in Immunology·2023· 20 citedOpen Access
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
Biomarker Research·2023· 1 citedOpen Access
Pan-cancer immunogenic death analysis identifies key roles of CXCR3 and CCL18 in hepatocellular carcinoma
Genes & Diseases·2023· 3 citedOpen Access
Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
2023Open Access
Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
2023Open Access
Quantitative Characterization of Intertumor Heterogeneity of Primary Cardiac Diffuse Large B-Cell Lymphoma Using Cardiac Magnetic Resonance
Circulation Cardiovascular Imaging·2023
Complete response to sotorasib as neoadjuvant treatment in patient with locally advanced primary pulmonary sarcoma harboring KRAS mutation: a case report
Annals of Translational Medicine·2022· 1 citedOpen Access
Observation on the Effect of Spontaneous Ventilation Single-Port Thoracoscopy and Conventional Thoracoscopy on T Lymphocyte Subsets and Inflammatory Factors in Patients with Non-Small Cell Lung Cancer
Proceedings of Anticancer Research·2022Open Access
Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma
Frontiers in Immunology·2022· 21 citedOpen Access
TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine
The EPMA Journal·2022· 9 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Xiujuan Qu(36), Xiaofang Che(33), Yunpeng Liu(28), Yibo Fan(27), Kezuo Hou(26), Ling Xu(19), Zhi Li(13), Ti Wen(11), Yanju Ma(10), Yunpeng Liu(8), Tianshu Guo(8), Ye Zhang(7), Rui Ma(7), Xuejun Hu(7), Xiujuan Qu(6), Xiaoxun Wang(5), Yuee Teng(5), Na Song(5), Jinglei Qu(4), Shuo Wang(4)